These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19000676)

  • 1. The natural history of nonalcoholic fatty liver disease: insights from children and mice.
    Ahima RS
    Gastroenterology; 2008 Dec; 135(6):1860-2. PubMed ID: 19000676
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease.
    Choudhury J; Sanyal AJ
    Clin Liver Dis; 2004 Aug; 8(3):575-94, ix. PubMed ID: 15331065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
    den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty liver and the metabolic syndrome.
    Neuschwander-Tetri BA
    Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of fatty liver in children and adolescents.
    Schwimmer JB; Deutsch R; Kahen T; Lavine JE; Stanley C; Behling C
    Pediatrics; 2006 Oct; 118(4):1388-93. PubMed ID: 17015527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: hepatic steatosis and insulin resistance.
    Lonardo A; Lombardini S; Ricchi M; Scaglioni F; Loria P
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():64-70. PubMed ID: 16225477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-alcoholic fatty liver disease in children: a new complication of obesity].
    Bocca G; Stolk RP; Scheenstra R; Sauer PJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2443-7. PubMed ID: 19051794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, hepatic metabolism and disease.
    Edmison JM; Kalhan SC; McCullough AJ
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 63():163-72; discussion 172-6, 259-68. PubMed ID: 19346775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic complications of childhood obesity: identifying and mitigating the risk.
    Weiss R; Kaufman FR
    Diabetes Care; 2008 Feb; 31 Suppl 2():S310-6. PubMed ID: 18227502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: a 1-year follow-up study.
    Reinehr T; Toschke AM
    Arch Pediatr Adolesc Med; 2009 Aug; 163(8):709-15. PubMed ID: 19652102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical observation paper: fatty liver and metabolic syndrome: is it a burden for the future generations?
    Nobili V; Agostoni C
    Metabolism; 2010 Jun; 59(6):831-3. PubMed ID: 20005539
    [No Abstract]   [Full Text] [Related]  

  • 14. Pediatric nonalcoholic fatty liver disease in 2009.
    Alisi A; Manco M; Vania A; Nobili V
    J Pediatr; 2009 Oct; 155(4):469-74. PubMed ID: 19772998
    [No Abstract]   [Full Text] [Related]  

  • 15. [Obesity as a risk factor in hepatobiliary diseases].
    Oguma M; Harada T
    Nihon Rinsho; 1988 Nov; 46(11):2443-7. PubMed ID: 3241367
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease.
    Hjelkrem MC; Torres DM; Harrison SA
    Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The liver and the waistline: Fifty years of growth.
    Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S105-18. PubMed ID: 19799688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children.
    Nobili V; Marcellini M; Marchesini G; Vanni E; Manco M; Villani A; Bugianesi E
    Diabetes Care; 2007 Oct; 30(10):2638-40. PubMed ID: 17536073
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advances in the epidemiological study of fatty liver].
    Zhang HJ; Zhuang H; Liu XE
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):630-2. PubMed ID: 15308049
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid metabolism during lactation: a review of adipose tissue-liver interactions and the development of fatty liver.
    Vernon RG
    J Dairy Res; 2005 Nov; 72(4):460-9. PubMed ID: 16223462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.